Estradiol has been shown to cause an increase in dendritic spine density in cultured hippocampal neurons, an effect mediated by downregulation of brain-derived neurotrophic factor (BDNF) and glutamic acid decarboxylase (GAD), and the subsequent phosphorylation of cAMP response element binding protein (CREB) in response to enhanced activity levels. Interestingly, progesterone was shown to counteract the effects of estradiol on dendritic spine density in vivo and in vitro. The present study examined how progesterone may act to block the effects of estradiol in the molecular cascade of cellular events leading to formation of dendritic spines. Progesterone did not affect the estradiol-induced downregulation of BDNF or GAD, but it did block the effect of estradiol on CREB phosphorylation. The latter effects of progesterone on the pCREB response and spine formation were reversed by indomethacin, which prevents the conversion of progesterone to the neurosteroid tetrahydroprogesterone (THP). We therefore examined if the progesterone effects were caused by its active metabolite THP. Progesterone treatment caused a 60-fold increase in THP in the culture medium. THP itself enhanced spontaneous GABAergic activity in patch-clamped cultured neurons. Finally, THP blocked the estradiol-induced increase in spine density. These results suggest that progesterone, through conversion to THP, blocks the effects of estradiol on dendritic spines not via a direct nuclear receptor interaction but by counteracting the enhanced excitability produced by estradiol in the cultured network.

Keywords:
Gonadal steroids, Hippocampus, Dendritic spines, Ontogeny, Nerve growth factors, Glutamic acid decarboxylase, Cyclic AMP, GABA, Electrophysiology, CREB
1.
Woolley CS, Gould E, Frankfurt M, McEwen BS: Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035–4039.
2.
Woolley CS, McEwen BS: Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293–306.
3.
Murphy DD, Segal M: Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 1996;16:4059–4068.
4.
Murphy DD, Cole NB, Segal, M: BDNF mediates estradiol-induced dendritic spine formation in hippocampal neurons. Proc Natl Acad Sci USA 1998;95:11412–11417.
5.
Murphy DD, Cole NB, Greenburger V, Segal M: Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 1998;18:2550–2559.
6.
Murphy DD, Segal M: Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc Natl Acad Sci USA 1997;94:1482–1487.
7.
Weiland NG, Orikasa C, Hayashi S, McEwen BS: Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J Comp Neurol 1997;388:603–612.
8.
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004–1007.
9.
Lan NC, Gee KW: Neuroactive steroid action at the GABAA receptor. Horm Behav 1994;28:537–544.
10.
Wilson MA: GABA physiology: Modulation by benzodiazepines and hormones. Crit Rev Neurobiol 1996;10:1–37.
11.
Baulieu EE: Neurosteroids: Of the nervous system, by the nervous system, and for the nervous system. Recent Prog Horm Res 1997;52:1–32.
12.
Papa M, Bundman MC, Greenberger V, Segal M: Morphological analysis of the development of dendritic spines in primary cultures of hippocampal neurons. J Neurosci 1995;15:1–11.
13.
Berninger B, Marty S, Zafra F, Berzaghi M, Thoenen H, Lindholm D: GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro. Development 1995;121:2327–2335.
14.
Marty S, Berninger B, Carroll P, Thoenen H: GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. Neuron 1996;16:565–570.
15.
Kim YS, Zhang H, Kim HY: Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry. Anal Biochem 2000;277:187–195.
16.
Costa AM, Spence KT, Smith SS, Ffrench-Mullen JM: Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J Neurophysiol 1991;74:464–469.
17.
Penning TM, Sharp RB, Krieger NR: Purification and properties of 3 alpha-hydroxysteroid dehydrogenase from rat brain cytosol: Inhibition by the nonsteroidal anti-inflammatory drugs and progestins. J Biol Chem 1985;260:15266–15272.
18.
Maggi R, Poletti A, Casulari LA, Pimpinelli F, Piva F, Zanisi MR, Martini L: Effects and metabolism of steroid hormones in human neuroblastoma cells. Steroids 1998;63:257–262.
19.
He K, Woolf TF, Hollenberg PF: Mechanism-based inactivation of cytochrome P-450–3A4 by mifepristone (RU486). J Pharmacol Exp Ther 1999;288:791–797.
20.
Serres C, Yang J, Jouannet P: RU486 and calcium fluxes in human spermatozoa. Biochem Biophys Res Commun 1994;204:1009–1015.
21.
Gould E, Woolley CS, Frankfurt M, McEwen BS: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286–1289.
22.
Pelletier G, Luu-The V, Labrie F: Immunocytochemical localization of 5 alpha-reductase in rat brain. Mol Cell Neurosci 1995;5:394–399.
23.
Li X, Bertics PJ, Karavolas HJ: Regional distribution of cytosolic and particulate 5 alpha dihydroprogesterone 3 alpha-hydroxysteroid reductases in female rat brain. J Steroid Biochem Mol Biol 1997;60:311–318.
24.
Weiland NG, Orchinik M: Specific subunit mRNAs of the GABAa receptor are regulated by progesterone in subfields of the hippocampus. Mol Brain Res 1995;32:271–278.
25.
Smith SS, Gong QH, Hsu FC, Markowitz RS, Ffrench-Mullen JM, Li X: GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998;392:926–930.
26.
Deisseroth K, Bito H, Tsien: Signaling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal plasticity. Neuron 1996;16:89–101.
27.
Buterbaugh GG, Hudson GM: Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition. Exp Neurol 1991;111:55–64.
28.
Rodriguez Macias KA: Catamenial epilepsy: Gynecological and hormonal implications. Five case reports. Gynecol Endocrinol 1996;10:139–142.
29.
Segal M, Murphy DD: CREB activation mediates plasticity in cultured hippocampal neurons. Neural Plasticity 1998;6:1–7.
30.
Henderson VW: The epidemiology of estrogen replacement therapy and Alzheimer’s disease. Neurology 1997;48(suppl 7):S27–S35.
31.
Marczynski TJ: GABAergic deafferentation hypothesis of brain aging and Alzheimer’s disease revisited. Brain Res Bull 1998;45:341–379.
32.
Segal M: Dendritic spines for neuroprotection. Trends Neurosci 1995;11:468–471.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.